Work in progressFolivue is still being built, so expect rough edges. Found a bug? Report it on the roadmap. Enjoying it? Buy me a coffee.Expect rough edges. Found a bug? Report it. Folivue is free. Want to help? Buy me a coffee.

Market snapshot

USEuropeAsiaLatin AmericaCurrenciesCryptoFutures

Dow Jones----S&P 500----Nasdaq----Russell----VIX----

Home›

Compare to

In the news

Keep browsing

You may be interested in

Help Roadmap & feedback Support Folivue Privacy Terms Disclaimer

ToolsStock return calculator Export Google Finance portfolios and watchlist to CSV

GuidesGoogle Finance classic view, rebuilt The new Google Finance, reviewed honestly The Google Finance redesign, explained A Google Finance alternative for classic users A Yahoo Finance alternative for people who miss the old one Google Finance without the AI Why did Google Finance change? Not because users asked The Google Finance portfolio: what changed, and how to keep tracking About Folivue

Folivue is not affiliated with, endorsed by or sponsored by Google LLC, Alphabet Inc., Yahoo, or any exchange or index provider. Market data comes from third parties, may be delayed or inaccurate, and is not investment advice; all other names and marks belong to their owners. Read the full disclaimer.

Market snapshot

Dow Jones0.98%52,573.29+509.19 S&P 5000.86%7,656.98+65.28 Nasdaq0.96%26,333.04+251.34 Russell0.45%2,903.94+12.99 VIX11.99%17.74+1.90

Keep browsing

You may be interested in

MDLZMondelez International, Inc.$62.44
0.05%
GISGeneral Mills, Inc.$35.85
0.31%
PMPhilip Morris International Inc.$191.06
0.68%
PEPPepsiCo, Inc.

$136.32

0.24%

KRThe Kroger Co.$58.49

2.70%

OKLOOklo Inc.$36.22

9.18%

NNENANO Nuclear Energy Inc.$16.41

5.47%

LEUCentrus Energy Corp.$152.31

8.18%

SMALL CAP (SMLL.SA): Live Index Tracker & Chart | Folivue

Home›SMLL.SA • SAO

SMALL CAP

R$2,241.231.37%-31.07 Today

Closed: Sep 14, 5:14:56 AM UTC-3 · BRL · SAO · Disclaimer

$327.801.45%2.79%

IND FDO IMOBR$3,748.63IFIX.SA0.04%I DIVIDENDOSR$13,105.01IDIV.SA0.75%IFINANCEIROR$19,658.84IFNC.SA0.44%ICONSUMOR$2,928.00ICON.SA1.27%BDRXR$27,635.59BDRX.SA1.38%

In the news

StockUS listed securityUS headquartered

Previous closeR$2,272.30

Day rangeR$0.00 - 0.00

Year rangeR$0.00 - 0.00

GlobeNewswire•4 minutes ago

Johnson & Johnson’s RYBREVANT®▼ (amivantamab) plus chemotherapy delivers median overall survival of nearly three years in EGFR exon 20 insertion mutation-positive non-small cell lung cancer JNJ0.29%

GlobeNewswire•5 minutes ago

Small Molecule Drug Discovery Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook